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ABSTRACT 
Quantum dots (QDs), which are intensely fluorescent nanocrystals ranging 2-10 nanometers in 
diameter, have shown promise in fluorescence imaging. However, in vivo applications of QDs 
are limited due to the opaque surrounding of tissue and bones. In this study, InP/ZnS QDs were 
doped with a paramagnetic atom in an attempt to render them MRI-active. We have further 
bioconjugated these nanoprobes to develop highly specific MRI-active probes that can be used 
for detection of neurodegenerative diseases. These bioconjugated nanoprobes detect a mutated 
form of alpha-synuclein that forms oligomers that are a hallmark of Parkinson’s disease and 
other alpha-synucleinopathies. Here, we have optimized the doping of QDs with MRI-active 
metals (e.g. Gadolinium) and characterized the MRI activity. The resulting nanocrystals were 
further studied to assess the success of the paramagnetic atom’s incorporation into the crystal 
lattice and its performance as a probe for alpha-synucleinopathies such as Parkinson’s disease. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Quantum Dots 
Quantum dots (QDs) are highly fluorescent semiconductor nanocrystals that have size-
dependent optical properties. QDs are typically about 2-10 nm in diameter and composed of 
anywhere from hundreds to thousands of atoms1,2,3,4. QDs composed of group II-VI elements 
(e.g., CdS or CdSe) had been popular for use in biomedical research; however, studies have 
shown that Cd-based QDs can be degraded in a biological environment, leading to release of 
cytotoxic Cd2+ ions4. For this reason, researchers investigated alternative QDs with a more 
biologically compatible core, composed of group III-V elements (i.e. InP)3. Compared to 
conventional organic dyes, QDs are resistant to photobleaching, giving them the potential to be 
used long-term1. Additionally, they can be easily biofunctionalized for applications in 
biomedical research, diagnostics, and therapeutics4,5. 
QDs exhibit size-dependent optical properties, such as absorbance and 
photoluminescence, that fall in between a bulk semiconductor and discrete molecule6,7. The 
physical radius of a QD is smaller than the material’s Bohr radius, which is described as the 
separation between an excited electron in the conduction band and the hole it leaves in the 
valence band8. The confinement of electrons into a quantum box causes a conversion from 
continuous to discrete energy levels. For QDs with a smaller size, the difference in energy 
between valence and conduction bands is much larger, requiring more energy for excitation, but 
also releasing more energy as the electron returns to the ground state. As the size of the QD 
increases, the band gap decreases resulting in a red-shift (Figure 1)9. Because of this, the relative 
2 
size distribution in QDs can be observed as the full-width half maximum in a fluorescence 
emission spectrum. 
 
Figure 1: Band gap energy and emission of QDs10. The band gap of a respective QD has an 
inverse relationship with size, due to quantum confinement. The larger the size, the smaller the 
band gap and energy. 
 
 
During fluorescence, an excited electron can proceed through two different relaxation 
processes: radiative and non-radiative decay (Figure 2). In radiative decay, light is emitted as a 
result of relaxation. In the case of non-radiative decay, however, energy is released instead as 
heat, and electrons move from a high energy level to a meta-stable level6,7. Defects on the QD, 
also known as surface traps, act as sites for nonradiative decay. Some of the excited electrons can 
decay to these surface traps located mid band gap. They then nonradiatively recombine with the 
holes located in the valence band, reducing photoluminescence quantum yield8. Placing an 
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inorganic shell with a large bandgap over the QD core (sometimes referred to as “shelling”) can 
help to passivate these defects and improve fluorescence as well as photostability1. 
 
Figure 2: Jablonski energy diagram11. The Jablonski diagram shows different paths of relaxation 
an electron can proceed through after reaching an excited state. 
 
 
InP nanocrystals are prone to surface oxidation and photodegradation, and ultimately, 
poor fluorescence. To mitigate this, the InP core is often shelled as mentioned above, promoting 
stability and increasing photoluminescence5. In a Type I (e.g. InP/ZnS) core/shell composition, 
the conduction band of the shell is at a higher energy than the core, while the valence band is at a 
lower energy than that of the core, effectively confining both the electrons and their holes to the 
core (Figure 3)1,12. This has been shown to increase photoluminescence quantum yield by 
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reducing nonradiative recombination12. In deciding on a core and shell, the materials must have 
analogous crystal structure with lattice mismatch below a threshold to feasibly allow for shell 
growth (~12%)13. ZnS in advantageous as a coating material for InP QD cores since the lattice 
mismatch is only 7.6% and it is chemically stable and nontoxic12,13. 
 
Figure 3: Core/Shell bandgap distribution12. (a) In a Type I core/shell structure, the band gap of 
the shell material, pictured on either side of the core, confines both the electron and its hole to 
the core. (b) Positions of both valence and conduction bands for various semiconductor 
materials. ZnS’s band gap easily confines that of InP. 
 
 
1.2 Synthesis 
There are several methods for synthesizing QDs, but most relevant method for this work 
is hot-injection, where precursors are injected into the heated reaction mixture during synthesis14. 
Before the reaction is started, precursors for indium and zinc are added to a coordinating solvent, 
the temperature is increased, and an inert atmosphere is introduced. Addition of the phosphorous 
precursor initiates the crystallization of the QDs, which can be broken up into three stages: 
precursor conversion, nucleation, and growth. All three steps occur in rapid succession, making 
the study of the kinetics of crystallization difficult16. 
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In the first step, called precursor conversion, phosphine and indium species present in the 
reaction mixture interact to form InP monomers (Figure 4). One of the prevailing theories  
 
Figure 417: InP formation. (Scheme 1) InCl3 forms an adduct with the aminophosphine with a 
delocalized positive charge, allowing for (Scheme 2) a nucleophilic attack by a second 
aminophosphine group leading to an InP intermediate and phosphonium salt. (Scheme 3) Two 
more equivalents of the aminophosphine further reduce the phosphorous of the intermediate to 
an oxidation state of -III, forming InP. 
 
postulates that formation of InP from InCl3 and tris(dimethylamino)phosphine (TDMAP) is 
dependent on the type of coordinating solvent used17. In order for the reaction to take place, the 
coordinating solvent must have a primary amine, such as oleylamine17. This allows TDMAP to 
6 
undergo transamination, a nucleophilic attack from the phosphorous center of one TDMAP on 
the amino group of another. The resulting fully transaminated product then proceeds as a  
reactant. In order for this reaction to proceed, there must be ~4 times as much TDMAP as there 
is InCl3; 3 equivalents of transaminated aminophosphine reduce a fourth in order to form the InP 
monomer through oxidation and reduction17.  
Following the precursor conversion to InP, nucleation and growth occur. Classically, 
nucleation and growth are described using LaMer’s model that separates nucleation and growth 
into two steps, which is essential for synthesizing monodisperse nanocrystals (NCs). In this 
model, a rapid burst of nucleation occurs directly followed by the growth stage16. Here, this is 
achieved using hot-injection of a phosphorous precursor to trigger monomer formation, followed 
by a burst of nucleation. As nuclei form, the monomer concentration decreases, and NCs move 
into the growth stage18. During growth, NC size can increase when smaller NCs dissolve, a 
process called Ostwald ripening16. This effect can lead to a larger size distribution of NCs. 
Once core growth is terminated, shelling can be initiated. Previous work has suggested 
that oleylamine ligands and the zinc precursor species passivate the surface of the InP cores, 
providing a Zn-rich surface for growing ZnS shells (Figure 5)18. Shell formation is initiated by 
addition of a sulfur precursor (e.g. dodecanethiol). Additional shelling is facilitated by the 
addition of more zinc precursor, which improve photostability and quantum yield20. During 
shelling, dodecanethiol binds with the ZnS on the surface, becoming the surface capping ligand 
for the final core/shell QD product18. 
For QDs to be biologically relevant, they must be water-soluble, which requires 
exchanging the existing surface ligands for water-soluble ligands. 11-mercaptaundecanoic acid is 
often used as a water-soluble surface ligand due to its facile exchange and binding energy21. The 
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Zn-Sthiolate binding energy (194.7 kJ/mol) is higher in comparison to both a S-Sthiolate and Zn-Sthiol 
with binding energies of 105.1 kJ/mol and 31.8 kJ/mol, respectively22. Tetramethylammonium 
hydroxide (TMAH) is used as a base to deprotonate the thiol of MUA. The deprotonated MUA 
forms ion pairs with tetramethylammonium cations, allowing it to be transferred into the 
chloroform solvent. This gives rise to the bond between the thiolate and ZnS surface, allowing 
the QDs to ultimately be transferred to the aqueous phase21. 
 
Figure 5: Surface passivation of InP cores19. Leading up to shell formation, oleylamine ligands 
and zinc stearate passivate the surface of the cores. 
 
 
1.3 QD Doping 
One way to impart optical, magnetic, electrical, and electronic properties to QDs is by 
doping the structure with an impurity. Impurity states introduced by a dopant allow for high 
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quantum yield emissions and have been documented to cause a red-shift in emission, possibly 
due to dopant d-d levels or interaction of the dopant d level with the core material23. Examples 
have included Cu and Mn, with the latter showing a marked improvement in quantum yield23,24. 
Doping of QDs can be performed either extrinsically or intrinsically. Extrinsic doping is 
characterized by two types: charge injection methods or the use of certain surface ligands to 
induce further functionality of QDs24. Intrinsic doping involves doping the core of the QD by 
nucleation, growth doping, or ion diffusion24,25. In the ion diffusion method, the dopant precursor 
is incorporated into the reaction mixture prior to nucleation or growth. Ion diffusion can 
separately be broken down into cation exchange for diffusion doping23. In this work, doping is 
used to introduce Gd3+ as a core dopant using intrinsic methods. 
 
Figure 6: QD phase transfer21. InP/ZnS QDs shown on the left are in organic solvent (bottom 
phase) with dodecanethiol surface ligands. On the right, QDs transfer to the upper aqueous phase 
with MUA surface ligands. 
 
1.4 Magnetic Properties 
The desired properties of the QD determines the choice of dopant. Magnetic functionality 
has been of recent interest for its potential in multimodal imaging26,27. By imparting magnetic 
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properties to QDs, they could be used to provide contrast in magnetic resonance imaging (MRI), 
a method critical for clinical diagnostics in disease and injury26. Manganese (Mn2+) and 
Gadolinium (Gd3+) are the most common paramagnetic ions used as contrast agents for MRI. For 
this reason, they are being investigated for incorporation into QD structures26. By doping QDs 
with a paramagnetic ion, relaxivity per QD is larger than it would be per ion due to the ability for 
each QD to host many paramagnetic ions1,27. This characteristic is useful for magnetic probes 
with a molecular target. 
The magnetic properties of a paramagnetic ion are of particular interest for use in nuclear 
magnetic resonance (NMR). In a paramagnetic ion, there is a minimum of one unpaired electron, 
behaving as a tiny magnet. In the presence of a strong external magnetic field (B0), nuclear spins 
can adopt either a parallel or antiparallel orientation in relation to the external field (Figure 7); 
the nuclear spin represents the total angular momentum of a nucleus and is associated with a 
magnetic moment28,29. Of the two orientations, parallel alignment occurs as the lower energy 
state, making it the preferred alignment, though the energy difference between the states is 
relatively small29. This difference, however, results in a net magnetization vector (Mz) aligned to 
the magnet. Individual nuclei do not line up with the field but wobble, or precess, around the 
direction of the magnetic field at a frequency described by the Larmor equation28. 
In order to gain information regarding the nuclear spin, the direction of the net 
magnetization factor (Mz) must be changed to give a measurable signal. This is done by exciting 
the spins using radiofrequency (RF) pulses28,29. The energy from the RF pulse is absorbed by 
protons, thus allowing them to go from a parallel state to antiparallel. The spins then precess in 
phase, and Mz align 90 into the transverse plane. When the RF transmitter is off, nuclei return 
to their ground state, magnetization in the transverse plane decreases, and the induced signal 
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decreases, referred to as free induction decay (FID). The time it takes for the signal to return to 
equilibrium is the relaxation time28. 
 
Figure 7: Effect of magnetic field on nuclear spin28. Without a magnetic field, magnetic moments 
have random distribution. With the application of a strong external magnetic field, spins align in 
an antiparallel or parallel fashion. The net magnetization vector (Mz) runs parallel with B0. 
 
Relaxation can be described with two different constants: T1 (longitudinal) and T2 
(transverse). T1 is characterized by realignment with B0 toward a spin’s thermal equilibrium 
value. T2, however, is characterized by the decay of coherence: after an RF pulse, spins are in 
phase, but as time passes, the signal decreases as spins begin to dephase from inhomogeneities or 
spin-spin interaction. The T2 time is always shorter than T1. Signals from these measurements 
can be converted using Fourier transform to corresponding intensity, which is pixel mapped into 
shades of gray in an image (Figure 8)28,29.  
11 
Generating data for T1 and T2 times require different methods of data collection. 
Repetition time (TR) refers to the length of time between RF pulses applied to a sample. Time to 
Echo (TE) measures the time between the RF pulse and the echo signal. In general for T1, short 
TE and TR times are used, while T2 images are produced with longer TE and TR times28,29. 
 
Figure 8: T1 vs T2 weighted images30. Notable differences between T1 and T2 images in the brain 
are shown here. T1-weighted images show the cerebral spinal fluid (CSF) dark. In a T2 weighted 
image, however, CSF is bright with higher pixel intensity. 
 
 
1.5 Biomedical Application 
Parkinson’s disease (PD) is a neuromuscular disease characterized by the degeneration of 
dopaminergic neurons in the substantia nigra region of the brain. Usually by the time a patient 
starts presenting with motor impairment, >50% of dopaminergic neurons and up to 80% of 
synaptic activity are lost in this region, taking place over years preceding diagnosis31. The 
disease is often able to progress quite far before therapeutic intervention due to difficulties in 
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diagnosing PD and problems with patients self-reporting symptoms. Currently, to diagnose a 
patient with PD, a doctor must take a patient history and consider the symptoms reported by the 
patient. Because this decision is largely based on patient self-reporting, there is potential for 
inaccuracies. No definitive test exists at this time to diagnose a living patient, since PD can only 
be confirmed on autopsy with microscopic observation of the affected neurons31,32. 
One possible target for developing a diagnosis method lies with a defining trait of PD. 
The hallmark of PD is the presence of Lewy bodies, structures in the cytoplasm of neurons that 
contain aggregates of misfolded protein alpha-synuclein32,33. Alpha-synuclein is a 140-residue 
protein that has been shown to aggregate, or oligomerize, in disease states, interfering with 
neuron signaling33. Previous work in our lab has established a method by which QDs can be 
bioconjugated to a peptide that binds to toxic alpha-synuclein oligomers. Coupling this peptide-
binding detection method with Gd-doped QDs could allow for the development of an MRI-based 
method to detect and observe the progression of PD. 
 
1.6 Assessing QD Toxicity 
Before Gd-doped QDs can be used in biological applications, a toxicity assay should be 
performed to determine the effects of the presence of Gd in the Gd:InP/ZnS QDs. One way to 
determine toxicity of nanoparticles or drugs on cells is through a colorimetric assay based on 3-
[4,5-dimethylthizol-2-yl]-2,5 biphenyl tetrazolium bromide (MTT)34. Since most viable cells 
have constant mitochondrial activity, cellular viability can be measured by the activity of 
succinate dehydrogenase, a crucial mitochondrial enzyme. When MTT is in the presence of 
active succinate dehydrogenase, it is reduced to MTT-formazan, which is a purple crystal. Once 
MTT-formazan has formed inside the cells, the cells can be lysed using a detergent. The crystals 
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then are solubilized, and the formazan quantified via absorbance at 570 nm. An increase or 
decrease in formazan concentration depicts increased or decreased mitochondrial activity (i.e. 
cellular viability)35. In order to generate a standard curve to quantitate viability, cells are plated 
at concentrations appropriate to the cell line and are dependent upon rate of proliferation and 
mitochondrial activity; here, the cell were plated at 500 – 2,750 cells per well. Plating at too high 
of a cell density can lead to a plateau in cell growth from contact inhibition, exhaustion of cell 
medium, and exceeding maximal OD value for measurement. In order to assess the effect of a 
QD sample on cell viability, a range of QD concentrations replicating that usually used for cell 
treatment is selected. After plating cells at a concentration that falls in the range of the standard 
curve, cells are allowed to proliferate for 24 hours before being treated in triplicate with QDs for 
an additional 24 hours. After this, each well is treated as previously described with MTT and 
subsequently a detergent. The measured absorbance of the lysed QD-treated cells is compared 
against the lysed control cells (not treated with QDs) to determine the percent cell viability34,35.  
In InP/ZnS QDs, known for their decreased toxicity, were doped with Gd. The amount of 
Gd used in the initial reaction for core nucleation growth was varied to determine how much Gd 
was incorporated into the nanocrystal, and how this affected the relaxation time of the QD. 
Additionally, one QD synthesis was performed to attempt to incorporate Gd into the shell of the 
QD to see if the closer proximity of Gd to the surface (and thus nearby water molecules) would 
increase relaxation in comparison to core doping. Post-synthesis characterization by UV-Vis 
spectroscopy and fluorimetry was used to determine the optical properties and size distribution 
of each QD sample. Scanning Transmission Electron Microscopy (STEM) was performed to 
determine whether Gd had an effect on size or size distribution. To determine the success of 
doping, Inductively Coupled Plasma (ICP) spectroscopy was used to obtain molar ratios of 
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elements present in QDs and assess the amount of Gd incorporated into the QD. Further studies 
were done investigating the relaxation potential of samples and cell viability to determine the 
effect these QDs would have at similar concentrations to those seen in normal cell targeting 
studies. From this work, properties such as monodispersity, NMR relaxation potential, and 
cytotoxicity determine whether Gd:InP/ZnS QDs are indeed feasible as a diagnostic tool. 
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CHAPTER 2: EXPERIMENTAL 
 
2.1 Reagents 
All chemicals were purchased from Millipore Sigma (St. Louis, MO) except for the 
following: InCl3 99.995% (193190100, Acros Organics), GdCl3 anhydrous (93-6416, Strem), 
200 proof ethyl alcohol (200-CSPTP, Ultrapure), Sodium phosphate dibasic anhydrous (BP332-
500, FisherBiotech), 1-dodecanethiol (117625000, Acros Organics), methanol (A434-20, Fisher 
Chemical), and sodium dodecyl sulfate (SDS) (61-1043, BioPhore). 
 
2.2 Core/Shell QD Synthesis 
Prior to synthesis, all glassware was cleaned in a base bath of 8% KOH in 3:1 EtOH:H2O. 
The synthesis method used here was an adaptation from previous work36. 0.903 mmol InCl3 and 
1.83 mmol Zn stearate was added to a 100 mL round bottom flask (RBF) containing 30 mL 
oleylamine and a stir bar. The RBF was placed in a heating mantle over a stir plate and 
connected to a proportional-integral-derivative (PID) temperature controller with temperature 
probe. The mixture was stirred, and the RBF was placed under a vacuum for 1 hour, then the 
temperature was increased to 120C and the RBF was evacuated further for 20 minutes. The 
RBF was then filled with argon gas and the temperature raised to 230C and allowed to stabilize 
for 15 minutes. To initiate core nucleation and growth, 1 mL tris(dimethylamino)phosphine was 
quickly injected. After 9.5 minutes, the reaction was removed from heat and allowed to cool to 
200C to terminate core formation. The temperature was then increased to 240C and 6 mL 
dodecanethiol was slowly added to the reaction mixture to begin passivation of the QD cores 
with a ZnS shell. After 3 hours, an additional 1.85 mmol Zn stearate (dispersed in 10 mL 
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oleylamine) was slowly injected. The reaction was allowed to proceed for 3 more hours, then 
cooled to 60C, and 10 mL of hexanes added. The resulting solution was then transferred to a 50 
mL centrifuge tube and centrifuged at 3,000 x g for 10 minutes. To wash the QDs and remove 
excess organic ligands, the supernatant was separated into two 50 mL centrifuge tubes, 70% 
methanol: 30% chloroform was added to bring the total solution to 50 mL, and the solution was 
centrifuged again at 3,000 x g for 10 minutes. The resulting pellet was then redissolved in 10 mL 
chloroform and the washing step repeated two more times. QD samples were stored at -20C. 
For core doped QDs, in the initial reaction vessel, either 0.224 mmol, 0.336 mmol, or 0.336 
mmol GdCl3 was added to the original InCl3, Zn stearate, and oleylamine mixture before the 
reaction started. In the case of the shell doped sample, 0.224 mmol GdCl3 was suspended in 6 
mL dodecanethiol and slowly injected during shelling. 
 
2.3 UV-Vis Spectroscopy 
For UV-Vis spectroscopy, stock solutions of all samples were diluted 10-fold, with the 
exception of the shell-doped QDs, which were diluted 2-fold to preserve the signal-to-noise ratio 
in the spectra. QD samples were placed in a 60 L cuvette (path length of 0.3 cm) and scanned at 
a rate of 51 nm/min from 750 nm to 300 nm. For analysis of the data (particle size and 
concentration), calculations were used from literature on InP/ZnS QD kinetics37. To determine 
the stock concentration, the maximum wavelength and absorbance of the shoulder peak was 
used. To first determine particle size the following equation was used: 
 
𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑠𝑖𝑧𝑒 = 0.1456𝑒(0.0052 × ) 
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where  is the maximum wavelength of the shoulder peak. The extinction coefficient was then 
calculated using: 

106
= 0.0092(𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑠𝑖𝑧𝑒)3.959 
 
From here, Beer’s law was used to calculate the concentration of the solution: 
 
𝐴 = 𝜀𝐿𝑐 
 
where L is the path length of the cuvette, A is the absorbance at the maximum wavelength, c is 
concentration in units, and  is the previously calculated extinction coefficient.  
 
2.4 Fluorescence Spectroscopy 
To perform fluorescence spectroscopy, all samples were diluted to 1 M and the cuvette 
rinsed with chloroform between each sample. Emission spectra were collected using an 
excitation wavelength of 250 nm and data collected from 400-800 nm, covering the visible 
range. All slit widths were set to 5 nm and the step size and integration set to 1 nm and 1 sec 
respectively to reduce the signal to noise ratio and make it easier to elucidate all spectral 
characteristics.  
 
2.5 QD Water Solubilization 
Prior to ligand exchange, the QDs were washed again by adding 15 mL degassed ethanol 
to 5 mL QDs (a ratio of 3:1) and centrifuging at 3,000 x g for 5 minutes. The pellet was 
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resuspended in degassed chloroform, and the wash step repeated once more. 12.5 mmol 
tetramethylammonium hydroxide (TMAH) was dissolved in 25 mL of DI water to make a 0.5 M 
solution. 12.5 mmol of 11-mercaptoundecanoic acid (MUA) was then dissolved in this TMAH 
solution to make a final solution consisting of 0.5 M TMAH and 0.5 M MUA. Equal volumes of 
QDs in chloroform and 0.5 M TMAH/MUA were combined and stirred vigorously to create an 
emulsion for 12-24 hours. 
The solution was then centrifuged at 3,000 x g for 5 minutes to separate the organic and 
aqueous layers. The aqueous layer (top) was collected and the organic layer (bottom) was 
discarded, and the aqueous layer was further centrifuged at 17,000 x g to ensure full separation 
from organics. To purify the QDs, they were dialyzed for 4 days in 300 kD MWCO dialysis units 
against 4L 0.01 M phosphate buffer (pH 11.5) with frequent replacement of the buffer. The 
resulting samples were then filtered through a 0.22-micron filter in a 1 mL syringe to remove 
aggregates. Water soluble QDs were stored at 4C. 
 
2.6 Scanning Transmission Electron Microscopy (STEM) 
A 10 L volume of QD solution was pipetted onto ultrathin carbon on lacey carbon 
coated copper TEM grids (Tedpella PN: 01824). After 2 minutes of settling time, the excess 
solution was wicked away and the remaining volume was left to evaporate in a vacuum 
desiccator. The TEM grids were then imaged with a scanning transmission electron microscopy 
(STEM) detector on a thermal field emission scanning electron microscope (FESEM). Imaging 
was done with a KE Developments STEM detector in bright field mode on a JEOL 7600F 
FESEM at 30 kV acceleration voltage. 
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2.7 ICP/MS 
For QD sample preparation, approximately1 mg of each sample was dissolved in 1 mL of 
nitric acid and sonicated, and then an internal standard stock (ISS) was added to a final 
concentration of 5 L/mL. Each sample was then diluted to 10 mL with DDI water and nitric 
acid to a final concentration of 20% nitric acid. To create standard curves for each element, 
concentrations of 5,000, 10,000, and 50,000 ppb were used for P, S, Zn, and In; for Gd, 500, 
1,000, and 5,000 ppb standards were used. In the method used, P-31, S-34, and Zn-66 were 
monitored with Sc-45 as the internal standard (IS), In-255 with Cd-111 as the IS, and Gd-157 
with La-139 as the IS.  Each sample was run with a 60 sec uptake, 40 sec sample stabilization, 10 
sec water rinse, 10 sec acid rinse, and 20 sec probe rinse through 1.05 L/min nebulizer argon 
flow and a 1550 W plasma. The integration for all masses was 0.50 s. 
 
2.8 Cell Culture 
All cell culture reagents were purchased from HyClone (Logan, UT) except the 
following: Fetal bovine serum (35-010-CV, Gibco), 0.25% Trypsin-EDTA (25200-056, Gibco), 
Sodium Pyruvate (11360-070, Gibco), FluoroBrite™ DMEM (A18967-01, Gibco), and 96 well 
plates (353072, Falcon). N2a (mouse neuroblastoma) cells were a kind gift provided by Dr. 
Tania Q Vu at Oregon Health and Science University. 
In order to sustain the cell line, N2a cells were grown and split once every 2-3 days to 
maintain a suitable environment for healthy cells. When cells reached about 80% confluency, 
they were passaged using sterile technique in a biosafety cabinet. The media was aspirated from 
the cells, phosphate buffered saline (PBS) was added to wash away any excess media and 
aspirated away, and then trypsin added and the flask returned to the incubator for 4 minutes to 
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allow cells to detach from the surface of the flask. After this time, 3 mL DMEM was added and 
then mixture removed and placed in a 15 mL falcon tube. Here the mixture was then pipetted up 
and down to deaggregate cells before adding 0.5 mL of cells a new flask containing 5 mL of 
DMEM. Cells were returned to the incubator to incubate at 37C and 5% CO2. 
 
 
2.9 MTT Cell Viability Assay 
To generate a standard curve, N2a cells were plated into 96 well plates at 2,750, 2,500, 
2,250, 2,000, 1,750, 1,500, 1,250, 1,000, 750, 500, and 250 cells/well in triplicate. For each QD 
treatment, 1,500 cells/well were plated in triplicate. The plate was incubated at 37C and 5% 
CO2 for 24 hours. To assess the toxicity of the QDs on N2a cells, 6 concentrations ranging from 
250 pM - 500 nM of QDs were diluted with PBS. After the cells had incubated for 24 hours, a 
control of PBS and all 6 QD dilutions were applied in triplicate and the plates placed back in the 
incubator for another 24 hour period. Media was then replaced with 50 L FluoroBrite™ 
DMEM media and 50 L 0.5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) in PBS and the cells were incubated for 3 hours to allow for formazan crystal 
formation. To lyse cells and solubilize the crystals, an additional 150 L 10% SDS solution was 
added to each well and the cells were allowed to incubate for 30 minutes. The absorbance of 
each solution in the wells was then measured at 570 nm. 
 
2.10 Magnetic Resonance Image Acquisition 
MRI data were acquired on a 21.1 T (900 MHz) magnet at the National High Magnetic 
Field Laboratory (NHMFL) in Tallahassee, Fl. MRI scans were carried out on an ultra-wide bore 
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21.1 T (900 MHz) vertical magnet built at the NHMFL. The magnet was equipped with a Bruker 
Avance III console and data acquisition was performed with ParaVision 6.0.1 acquisition and 
processing (BioSpenCorp, Billerca, MA) software together with a 64 mm inner diameter high 
performance gradient (Resonance Research Inc, MA) capable of producing 0.6 T/m peak 
gradient strength. Different configurations and dilutions of the QDs were placed in 5-mm NMR 
tubes and 8 tubes at a time were imaged using a 33 mm home-built radio frequency (RF) coil. A 
Gd contrast agent gadodiamide (Omniscan™) and water were added as controls. All 
measurements were acquired with 2D axial orientation with a 150 x150 m in-plane resolution 
and 1.5 mm slice thickness. For T1 measurements, a turbo spin echo (SE) sequence was used. 
The echo time (TE) was 20 ms and incremented repetition times (TR) between 0.034-1.2s. T2 
relaxation were acquired with a multi slice multi echo (MSME) sequence using TR = 5,000 ms 
and incremented echo time (4.5 – 90ms). Regions of interest were placed within each tube and 
signal intensity data collected. Data were then fitted to an exponential rise to maximum (T1) and 
exponential decay (T2) functions using Matlab. 
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CHAPTER 3: RESULTS AND CONCLUSIONS 
 
3.1 QD Synthesis 
For the synthesis of all QD samples, hot injection synthesis was used. This method starts 
a burst of nucleation that then proceeds to the growth stage by rapidly injecting cooler precursors 
into the hot reaction mixture. In order to exclude any atmospheric water that may contribute to 
surface defects in the QDs, as well as affecting the hygroscopic precursor salts, the reaction must 
take place under an inert atmosphere. To achieve this, a vacuum was attached to the reaction set 
up and used to evacuate the system before subsequently flooding it with argon gas. A bubbler 
was added between the reaction set up and the vacuum as well as at the top exit vent for the inert 
gas. Five different samples were synthesized for this work using varying amounts of GdCl3, 
named based off the mmol of Gd used in the reaction: non-doped InP/ZnS, Gd:InP/ZnS (0.224 
mmol), Gd:InP/ZnS (0.336 mmol), Gd:InP/ZnS (0.448 mmol), and shell-doped Gd:InP/ZnS 
(0.224 mmol) QDs. 
In order to ensure the synthesis proceeded as expected, several defining steps in the 
reaction were studied (Figure 9). Firstly, as TDMAP was injected, the success of core formation 
was assessed on the color change that occured. The reaction mixture started as a pale yellow-
white color, but post-injection, began to darken, ultimately becoming a dark brown. Next, as 
dodecanethiol was added to begin shell passivation, successful shelling was assessed via UV 
radiation on the reaction mixture. If fluorescence is observed, the shelling process is likely 
proceeding, since InP cores are not inherently fluorescent. With every individual synthesis, 
samples appeared various shades of dark red under ambient light; however, when irradiated with 
UV light, the emitted fluorescent colors were more easily differentiated (Figure 10).  
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Figure 9: Appearance of QD synthesis under ambient light or UV light during core synthesis and 
shelling. A: Photo of QD synthesis under ambient light before injection of TDMAP. B: Photo of 
reaction mixture under ambient light after TDMAP injection and core formation. C: The reaction 
mixture following dodecanethiol injection as the mixture appears redder in ambient light. D: The 
final product of QDs with UV light to show fluorescence and a successful synthesis.  
 
Post-synthesis, samples were cleaned by adding hexanes to the mixture and centrifuging. 
As the QDs are soluble in hexanes, this step was meant to remove oleylamine and any excess 
precursor chemicals. It was noticed that for samples Gd:InP/ZnS (0.336 mmol), Gd:InP/ZnS 
(0.448 mmol), and shell-doped Gd:InP/ZnS (0.224 mmol) QDs that some of the QDs fell out of 
A B 
C D 
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suspension and became part of the pellet. It is possible that the incorporation of Gd into these 
samples led to an unstable crystal structure and a decrease in surface ligands, and ultimately, 
resulted in the QDs inability to remain in solution. After this step, all samples were washed twice 
with a solution of 70% methanol: 30% chloroform. If the QDs are washed more than this, it can 
potentially remove ligands from the surface of the QDs, making them unstable in organic 
solvent. 
 
3.2 Water Solubilization of QDs 
To impart biological relevance, it is imperative to transfer QDs from the organic solvent 
in synthesis into aqueous solution. This was achieved by exchanging the native dodecanethiol 
ligands present after synthesis with 11-mercaptoundecanoic acid (MUA), an amphiphilic 
molecule that can bind to the surface of the QD and has a terminal hydrophilic carboxylate 
moiety. The amount of MUA added was in excess of the amount theoretically needed to ensure 
the highest yield of water-soluble product possible.  The success of this method was assessed by 
centrifuging (~5,000 x g) the emulsion to separate the organic and aqueous layers. The QDs were 
observed to move from the organic layer on the bottom to the aqueous layer on top, which can be 
checked by UV light (Figure 11). When each sample was centrifuged, 3 layers typically were 
seen: the top aqueous layer, a middle layer in between the two phases where some QDs could be 
seen that weren’t fully water-soluble, and the bottom organic layer. Occasionally, the bottom 
organic layer evaporated overnight, decreasing the visibility of an organic layer. To remove any 
aggregates and move samples into a buffer, all samples were dialyzed and subsequently put 
through a syringe filter. Samples were then stored at 4C and observed to be stable for many 
months. If a sample is not stable, a pellet will form in the bottom of the centrifuge tube. 
25 
 
Figure 10: Synthesized QD samples under ambient and UV light. A: A diluted sample from each  
QD synthesis is shown as it appeared under ambient light. B: Each diluted sample is shown as it 
appeared to the eye under UV light.  
 
InP/ZnS          Gd:InP/ZnS       Gd:InP/ZnS        Gd:InP/ZnS        Gd:InP/ZnS 
                     (0.224 mmol)      (0.336 mmol)     (0.448 mmol)      shell-doped 
 
InP/ZnS          Gd:InP/ZnS       Gd:InP/ZnS        Gd:InP/ZnS        Gd:InP/ZnS 
                     (0.224 mmol)      (0.336 mmol)     (0.448 mmol)      shell-doped 
 
A 
B 
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3.3 Absorbance and Fluorescence Spectroscopy 
As a starting place for characterization, absorbance and fluorescence spectra were 
collected for all the samples. Using the absorbance spectra, the size and concentration of QDs 
were determined. In order to get the data points for calculations, the maximum wavelength at the 
shoulder and the corresponding wavelength were taken. By calculating the particle size via 
calculations produced by previous studies38, the extinction coefficient was also determined, and 
subsequently, the concentration. The fluorescence emission spectra showed a relative size 
distribution of QDs in a sample via its full-width half maximum (FWHM). This gave a relative 
particle size distribution as well as showed potential spectroscopic characteristics indicating QD 
defects38. Defects in the surface of the nanocrystal creates traps, or nonradiative recombination 
sites, causing weak fluorescence. 
Figure 11: Stages of water solubilization. A: Before QDs were solubilized, they were on the 
bottom layer in the organic phase, with the TMAH-MUA mix on top. B: QDs were placed on a 
stir plate with a stir bar to create an emulsion between the two phases. C: After centrifugation the 
QDs can be seen in the top layer. The middle layer usually seen prevails in this picture, likely 
due to evaporation by the organic layer during solubilization. 
 
 
A B C 
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The syntheses performed here produced QDs ranging from ~3-3.6 nm, calculated based 
on absorption data collected for each sample (Figure 12). The particle sizes calculated via UV-
Vis spectra can be correlated with color of the QD, further confirmed through the fluorescence 
emission spectra (Figure 13). From largest to smallest particle size, the QD samples are 
Gd:InP/ZnS (0.448 mmol), InP/ZnS, Shell-doped Gd:InP/ZnS, Gd:InP/ZnS (0.336 mmol), and 
Gd:InP/ZnS (0.224 mmol). This same trend is followed in the fluorescence data with the largest  
 
Figure 12: QD particle size. In the samples with 0.224 mmol and 0.336 mmol Gd added to the 
reaction, there appears to be a slight decrease in particle size. It is possible that during the 
synthesis water was present in the system inhibiting growth, leading to the change in size seen 
here39. 
 
 
QD being the most red shifted, and the smallest shifted more toward the blue.  No particular 
trend was found in respect to concentration, though all core-doped samples had a higher 
concentration than both the non-doped and shell-doped, which were fairly similar. The highest 
concentration sample was that of Gd:InP/ZnS (0.336 mmol) that was calculated to be 56.5 M, 
much higher than any of the others. Gd:InP/ZnS (0.224 mmol) and (0.336 mmol) had 
concentrations 13 M and 22 M respectively while both non-doped and shell-doped QDs came 
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to around 8 M.  To note, calculations for Gd-doped dots were not verified due to the complexity 
of the calculations, and thus by using the calculations for non-doped dots, error may have been 
introduced. Due to the difference in atomic radii size between In and Gd, and the assumption Gd 
is replacing In, the larger radii from Gd could be skewing the calculations somewhat, giving an 
artificially higher concentration.   
 
Figure 13: UV-Vis Absorption Spectra of non-doped and Gd-doped InP/ZnS QDs. UV-vis 
spectra of QD samples were collected, and the maximum of the shoulder was used to calculate 
average particle size and final concentration of the synthesized sample. 
 
From the stock concentrations, each QD product was diluted to ~1 M and the 
fluorescence spectra were obtained. These spectra were analyzed to discern the overall size 
distribution of QD nanoparticles (Figure 14). Addition of Gd did not seem to have an appreciable 
effect on size distribution. Non-doped QDs and Gd:InP/ZnS (0.0224 mmol) both had similar 
FWHM at around 62 nm. Gd:InP/ZnS (0.336 mmol) measured with a FWHM around 75 nm, 
Gd:InP/ZnS (0.448 mmol) around 68 nm, and shell-doped Gd:InP/ZnS around 71 nm. 
Commercially available InP/ZnS QDs with low size distributions exhibit a FWHM below 70 
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nm10,40. Thus, it does not appear that incorporation of Gd had an effect on particle size. However, 
this larger size distribution is potentially due to the fact that these reactions were scaled-up to 
produce sufficient QD products for the characterization herein. It is possible that increasing the 
scale of these reactions affected the reaction kinetics. Future work on this project may attempt to 
optimize size distribution of QD products at this scale. Additionally while observed by eye that 
the Gd:InP/ZnS (0.448 mmol) sample is more red-shifted than that of undoped InP/ZnS, both 
samples share a close lambda maximum for emitted wavelengths. The differences in these 
observations are likely due to the overlap in size distributions of the particles, with the majority 
of QDs synthesized with less Gd slightly blue-shifted. 
 
Figure 14: Fluorescence Emission Spectra of non-doped and Gd-doped InP/ZnS QDs. 
Fluorescence spectra of QDs show the relative size distribution of QDs in solution. As the QD 
size increases, the spectra become more red-shifted. 
 
 
 
3.4 Scanning Transmission Electron Microscopy 
Following synthesis, samples of different QDs were sent for Scanning Transmission 
Electron Microscopy (STEM) analysis at Jordon Valley Innovation Center (JVIC) (Springfield, 
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MO) to assess the size and shape dispersity of the nanoparticles. Non-aggregated, monodisperse 
particles are important for biological studies due to the unpredictability of aggregates. Non-
doped InP/ZnS, Gd:InP/ZnS (0.224 mmol), and Gd:InP/ZnS (0.336 mmol) were imaged in this 
study (Figure 15). Non-doped QDs demonstrate some aggregation in the micrographs with 
clusters of 7-8 QDs closely bunched together throughout the image. It is possible, while diluting 
 
Figure 15: STEM micrographs demonstrating monodispersity of QDs. STEM images of non-
doped and Gd-doped InP/ZnS QDs showing the monodispersity of (a) InP/ZnS QDs, (b) 
Gd:InP/ZnS (0.224 mmol), and (c) Gd:InP/ZnS (0.448 mmol) QDs. For each image, an insert 
shows a zoomed in area of the displayed image. A scale bar for the insert was calculated and 
generated based on the size of each pixel in the image. 
 
 
this sample to a sufficient concentration for imaging, the sample could have become unstable. 
Previous observations in our lab have shown that samples are not stable at very low 
A B 
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concentrations. Regardless, individual QDs appeared monodisperse in size and shape. Gd-doped 
samples appeared clearly monodisperse and can be easily differentiated from each other, 
demonstrating that incorporation of Gd at the amounts used in these syntheses does not have an 
appreciable effect on the shape or size of the nanoparticles. Analysis of the micrographs showed 
the samples have a size of ~3.5 nm, which closely matched with the estimated size of the 
InP/ZnS QDs through calculations (Figure 12). While it would be interesting to see the STEM 
imaging results for Gd:InP/ZnS (0.448 mmol) and shell-doped Gd:InP/ZnS QD samples, 
research limitations prevented collection of this data. 
 
3.5 Elemental Analysis via Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) 
In order to determine the amount of Gd incorporated into the QDs and the elemental 
composition of the nanoparticles, ICP-MS was performed. Three separate ICP-MS analyses were 
performed for each sample (Figure 16). The ratio of Zn to S is less than one for all QD samples 
analyzed, indicating an abundance of sulfur. However, this is likely attributed to the presence of 
S in the dodecanethiol ligand coating the exterior of the QD. Additionally, this analysis reveals 
that an increased amount of Gd in the reaction corresponded to an increase in the amount of Gd 
incorporated into the QD. However, the ratio of Gd/In does not increase at the same molar ratio 
at which it is incorporated, which is may be due to the kinetics of the reaction and presents 
opportunities for future work in this area. Further, results indicated a discrepancy in the ratio of 
Gd and In to P. The expected ratio would be 1:1; however for Gd:InP/ZnS (0.224 mmol) the 
ratio was 1.56. This observation could be an indication of oxidation, with a decrease in P being 
seen as a result.  
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Figure 16: Elemental analysis of QD samples analyzed via ICP-MS. Using ICP, the molar ratios 
of Zn:S, (In+Gd):P, and Gd:In were found. This was used to determine the success of the 
synthesis as well as the amount of Gd incorporated into the QDs.  
 
 
3.6 MRI Contrasting Capabilities 
In order to investigate MRI capabilities of the QDs, water-solubilized QD samples were 
sent to Dr. Jens Rosenberg at the National High Magnetic Field Lab (Tallahassee, Florida). 
Three concentrations (1M, 500 nM, and 100 nM) of QD solution were analyzed. While 
nanomolar concentrations are relevant in in vivo application of QDs, a concentration of 1 M 
was also used since it is most likely to have visible contrast41,42. For each sample, both T1 and T2 
relaxation data was gathered. 
For the samples sent for characterization, the image maps generated for T1 and T2 
relaxation were compared to a conventional contrasting agent used in clinical MRI, gadodiamide 
(Omniscan™). When the analysis was performed, the data for the top and bottom rows of Figure 
33 
17 were taken separately from each other. Samples in the top row (dissolved in a PBS) appeared 
brighter because the software scaled the image to the brightest voxel. In the top row, the brightest 
voxel was from water, making the samples appear bright, though their relaxation time was not 
actually considerably short (Figure 17, Figure 18). For the bottom row of samples and the PBS 
control, however, samples were scaled to gadodiamide. In T1 contrast if the relaxation time is 
short, one would expect a bright contrast. The samples in the bottom row of Figure 17 appear  
 
Figure 17: Mapped T1 relaxation times for QD samples. Samples were measured in an NMR 
with a 21.1 Tesla magnet fitted with an imaging probe. Pixels in the top row were scaled to the 
brightest pixel of the water sample, while pixels in the bottom row were scaled to the brightest 
pixel of the Omniscan sample. 
 
 
darker than the top row because the samples on the bottom row were scaled to gadodiamide 
(with a very low T1 of 15.9 ms). When comparing both the images and relaxation times, a 
modest increase in brightness in the samples can be seen, especially when compared with the 
PBS control. Additionally there is a modest decrease in relaxation time for the more concentrated 
samples of Gd:InP/ZnS (0.448 mmol) and shell-doped Gd:InP/ZnS QDs. While a relatively small 
amount of Gd was added to the shell-doped sample (0.224 mmol), the relaxation displayed by 
the shell-doped sample is much more comparable to a higher doped sample. This is likely a  
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Figure 18: Average T1 relaxation times for QDs. While modest, Gd:InP/ZnS (0.448 mmol) and 
shell-doped Gd:InP/ZnS QDs at higher concentrations show a decrease in T1 time compared to 
PBS. 
 
result of the Gd being closer to the surface of the QD, and as a result, causing a more noticeable 
relaxation in the nearby water molecules. However, the relaxation times for these QD samples 
were around 2200 ms and above; since promising contrast agents are typically below 1000 ms, 
T1 contrast does not appear to be a suitable modality for these QDs43. 
Gd-doped QDs show a more prominent potential as a T2 contrast agent. All images in 
Figure 19 were scaled to gadodiamide, which has a T2 time too short for it to be visually 
noticeable. Both Gd:InP/ZnS (0.448 mmol) and shell-doped QD images are visibly darker than 
that of the PBS control or undoped QD images.. Additionally, these samples demonstrate a clear 
reduction in relaxation times compared to the PBS control (Figure 20). T2 relaxation for the PBS 
control was around 400 ms, while samples from both the Gd:InP/ZnS (0.448 mmol) and shell-
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doped Gd:InP/ZnS samples had relaxation times around 100-140 ms and 180-190 ms 
respectively in the 1 M and 500 nM concentrations. The typical contrast agent has a T2  
 
Figure 19: Mapped T2 relaxation times for QD samples. Samples were measured in an NMR 
with a 21.1 Tesla magnet fitted with an imaging probe and scaled to Omniscan. The Omniscan 
T2 relaxation was much shorter than the samples, which caused it to be too dark to appear. 
 
 
relaxation of 100 ms or lower43. As with T1, the shell-doped sample shows improved contrast, 
similar to Gd:InP/ZnS (0.448 mmol). The Gd in this sample, however, was closer to the surface 
of the QD, thus closer to the aqueous solvent and likely allowing a larger effect on water 
molecules. Comparatively, the contrast seen in the QD samples was modest compared with 
gadodiamide, which has a relaxation around 9.3 ms. 
 
3.7 MTT Cell Viability Assay 
In order for Gd-doped QDs to be a feasible diagnostic tool, the cytotoxicity must be 
examined. Here, toxicity was studied using an MTT assay, which uses cellular respiration as a 
baseline for viability. A wide range of QD concentrations were used to assess cellular viability. 
QD concentrations of 100 nM- 500 nM were chosen to assess the viability in the concentration 
range that contrast data is often acquired41. Additionally, lower concentrations (250 pM- 1 nM) 
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were chosen to assess viability in the concentration range that is typically used for cellular 
labeling41. 
 
Figure 20: Average T2 relaxation times for QDs. For both Gd:InP/ZnS (0.448 mmol) and shell-
doped Gd:InP/ZnS QDs, there was a noticeable decrease in T2 relaxation when compared against 
the control, presenting potential for use as an MRI contrasting agent. 
 
A decrease in viability was observed in cells treated with higher concentration of the QD 
samples, especially for shell-doped Gd:InP/ZnS (Figure 21). For the cells treated with 250 pM – 
1nM QDs, the cell viability remains above 80%. However, a trend can be seen that with 
increased Gd content, there is a decrease in cell viability. For higher concentrations (100 nM- 
500 nM), cell viability decreased in both non-doped and shell-doped samples. In the case of the 
non-doped samples, it is possible that at this concentration particles begin to aggregate onto the 
cells, resulting in toxicity. STEM micrographs indicate that this sample was more prone to 
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aggregation (Figure 3.7). For shell-doped QDs, Gd was closer to the surface of the QD; 
therefore, Gd is more likely to be released into the surrounding medium. At 250 nM and 500 nM, 
QDs with the highest Gd content (0.448 mmol) cause a decrease in cell viability below 80 %. 
While higher concentrations of QDs show cytotoxicity, these concentrations are not typically 
used in cellular labeling applications41. QD concentrations usually used for cell targeting show 
little effect on cell viability. 
Figure 21: MTT Viability Assay for non-doped and Gd-doped InP/ZnS QDs. For most samples 
cellular viability does not decline below 80 % until 100 nM and above. However, for labeling, 
cells are usually not treated with concentrations over 100 nM QDs. 
 
3.9 Conclusions and Future Work 
This work represents a preliminary study of newly-synthesized Gd-doped QDs and their 
utility as an MRI contrast agent. Through absorbance data, particle size and concentration were 
calculated for each sample. The particle size was then compared to the lambda max of each 
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fluorescence spectrum. Furthermore, the fluorescence spectra FWHM were analyzed for the size 
distribution of the nanoparticles and potential contamination by water during synthesis. Particle 
size via STEM data was correlated to particle size via absorbance calculations and found to be in 
relative agreement (Figure 12). ICP-MS data demonstrated that the ratio of (Gd+In):P was higher 
than expected for Gd:InP/ZnS (0.224 mmol) and Gd:InP/ZnS (0.336 nmol) suggesting that 
oxygen may have been incorporated into the crystal lattice in place of P (Figure 16). Both of 
these samples have a smaller average size than the rest of the samples which is also indicative of 
oxidation (Figure 12). Assessing the samples for MRI contrast showed moderate imaging 
capabilities of Gd:InP/ZnS (0.448 mmol) and shell-doped QDs. While the contrast for T1 was 
minimal, T2 presented much better contrast for these samples. When assessing the toxicity of the 
QD samples, Gd-doped QDs do not appear to have a negative impact on cell viability within 
concentrations used for normal cellular labeling. 
Future work could investigate using Manganese2+ as the shell-doping agent, due to its 
biocompatibility and paramagnetism. Additionally, samples could be PEGylated to assess the 
MRI capabilities, since it is expected that the highly hydrophilic nature of PEG may bring water 
molecules closer to the QD surface, and thus paramagnetic ions.  As seen in the results, it is 
possible the kinetics of the original synthesis reaction were affected when the synthesis was 
scaled up, which could also be further optimized. Additionally, there is potential that more Gd 
could be incorporated into the crystal structure. More syntheses could be performed with 
increased mmol amounts of Gd until potentially QDs are unable to be formed. This work 
provides many potential avenues for further development and optimization for an MRI-active 
QD. 
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